A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

Source:http://linkedlifedata.com/resource/pubmed/id/16154196

Download in:

View as

General Info

PMID
16154196